Nobel Ilac A.S

Who are we?

Nobel İlaç has been active in the international market with a national capital from 1964 until today and develops pioneer and novelist products which increases the life quality by using the resources productively with the principle of being a worldwide trustworthy organization.
Nobel İlaç has been listed among the fastest growing 100 companies and holds the leadership in exportation among the Turkish medicinal firms.
Such success of Nobel İlaç is based on product development, manufacturing and sales-marketing strategy conducted in Turkey and in the world.

Nobel İlaç in Turkey and in the world:

The headquarters of Nobel İlaç holding is in Ümraniye. Research and development activities are conducted in the manufacturing site and R&D center in Düzce. Drug raw material and micro pellet manufacturing is conducted In Ulkar Kimya in Çerkezköy.
Besides the manufacturing sites in Turkey, Nobel İlaç has two more manufacturing sites in Kazakhstan and Uzbekistan. The world standard products manufactured in these facilities are presented to the surrounding countries. Our facility located in Kazakhstan is the largest of the Central Asia and is the first drug manufacturing facility receiving GMP in Kazakhstan.
Our product portfolio is as follows:

From 1964 until today, Nobel İlaç has provided quality and affordable drug alternatives to the Turkish people and to the world, which is still active inside and outside the country with almost 100 products.
Such products can be grouped as follows:
• Painkillers and rheumatism drugs
• Antibiotics and fungicides
• Cold drugs
• Digestion system drugs
• Urinary system drugs
• Cardiovascular system drugs
• Central nervous system drugs
• Supplementary nutrients such as probiotics, fish oils
• Vitamins and mineral supplements for empowering the immune system, products for bone joints and cartilage health, hair-nail and skin health products, cosmetics, personal hygiene and care products.

Company’s Keywords:

otc sales, generic drugs manufacturing & sales, contract manufacturing, drug development, marketing